|
|
|
Insider
Information: |
Baker G Leonard Jr |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,066,812 |
|
Indirect Shares
|
10,825,897 |
|
|
Direct
Value |
$44,243,397 |
|
|
Indirect Value
|
$180,412,926 |
|
|
Total
Shares |
11,892,709 |
|
|
Total
Value |
$224,656,323 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mattersight Corporation |
MATR |
10% Owner |
2014-06-12 |
7,981 |
2014-06-12 |
2,633,587 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2023-07-17 |
1,046,631 |
2023-07-17 |
4,263,565 |
Premium* |
|
Dextera Surgical Inc |
DXTR |
10% Owner |
2006-02-08 |
8,360 |
2014-01-01 |
3,790,923 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
3,840 |
2014-10-01 |
132,161 |
Premium* |
|
Quinstreet, Inc |
QNST |
10% Owner |
|
0 |
2010-02-10 |
5,661 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-09-28 |
4 |
A |
$0.00 |
$0 |
I/I |
27,641 |
955,055 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2015-09-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(280,365) |
0 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2016-01-01 |
5 |
GD |
$0.00 |
$0 |
I/I |
0 |
2,613,634 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2016-05-06 |
4 |
B |
$4.79 |
$211,886 |
D/D |
44,200 |
721,038 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2016-05-09 |
4 |
B |
$4.88 |
$128,380 |
D/D |
26,302 |
747,340 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2016-05-10 |
4 |
B |
$5.00 |
$147,629 |
D/D |
29,498 |
776,838 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2016-09-30 |
5 |
GD |
$0.00 |
$0 |
I/I |
0 |
2,613,634 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-11-13 |
4 |
S |
$17.59 |
$527,556 |
D/D |
(30,000) |
776,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-11-13 |
4 |
OE |
$2.70 |
$81,000 |
D/D |
30,000 |
806,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-05-11 |
4 |
S |
$16.01 |
$480,312 |
D/D |
(30,000) |
776,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-05-11 |
4 |
OE |
$2.23 |
$66,900 |
D/D |
30,000 |
806,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-08-14 |
4 |
B |
$12.47 |
$1,247,000 |
D/D |
100,000 |
876,838 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-08-15 |
4 |
B |
$12.49 |
$994,967 |
I/I |
79,686 |
2,693,320 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-08-16 |
4 |
B |
$12.49 |
$1,248,760 |
I/I |
100,000 |
2,793,320 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-08-17 |
4 |
B |
$12.80 |
$74,117 |
I/I |
5,792 |
2,799,112 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-08-20 |
4 |
B |
$12.92 |
$461,095 |
I/I |
35,681 |
2,834,793 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-11-09 |
4 |
B |
$13.00 |
$226,564 |
D/D |
17,428 |
894,266 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-11-09 |
4 |
B |
$13.00 |
$528,658 |
I/I |
40,666 |
2,875,459 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-11-12 |
4 |
B |
$12.94 |
$410,008 |
D/D |
31,677 |
925,943 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-11-12 |
4 |
B |
$12.94 |
$956,698 |
I/I |
73,914 |
2,949,373 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-11-13 |
4 |
B |
$12.87 |
$327,105 |
I/I |
25,420 |
2,974,793 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-11-13 |
4 |
B |
$12.87 |
$140,197 |
D/D |
10,895 |
936,838 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-11-21 |
4 |
B |
$12.73 |
$381,765 |
D/D |
30,000 |
966,838 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-11-21 |
4 |
B |
$12.73 |
$890,785 |
I/I |
70,000 |
3,044,793 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2019-02-12 |
4 |
B |
$11.39 |
$341,613 |
D/D |
30,000 |
996,838 |
2.39 |
- |
|
174 Records found
|
|
Page 6 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|